|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenues | |
| Operating expenses: | |
| Cost of goods sold | |
| Operations, general and administrative | |
| Sales and marketing | |
| Research and development | |
| Total operating expenses | |
| Operating income | |
| Stock amendment expense (Note 11) | |
| Interest income | |
| Interest expense | |
| Other income (expense), net | |
| Income (loss) before income taxes | |
| Provision (benefit) for income taxes | |
| Net income | |
| Adjustments to net income attributable to common stockholders (Note 2) | |
| Net income (loss) attributable to common stockholders | |
| Net earnings (loss) per share attributable to common stockholders (Note 2): | |
| Basic (in dollars per share) | |
| Diluted (in dollars per share) | |
| Weighted-average common shares outstanding: | |
| Basic (in shares) | |
| Diluted (in shares) |
Loading...
